SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-071919
Filing Date
2024-06-11
Accepted
2024-06-11 16:18:09
Documents
1
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 4/A ownership.html 4/A  
1 4/A ownership.xml 4/A 2949
  Complete submission text file 0000950170-24-071919.txt   4523
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MEREO BIOPHARMA 1 CAVENDISH PLACE LONDON X0 W1G 0QF
Business Address
Hughes-Wilson Alexandra (Reporting) CIK: 0002005875 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38452 | Film No.: 241036006